Literature DB >> 21116187

Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk.

Daniel C Beachler1, Lan L Gellert, Lisa P Jacobson, Richard F Ambinder, Elizabeth C Breen, Otoniel Martínez-Maza, Charles S Rabkin, Charles C Rabkin, Richard A Kaslow, Gypsyamber D'Souza.   

Abstract

Kaposi sarcoma-associated herpes virus (KSHV) infects B-cells and is found in non-Hodgkin lymphoma (NHL) B-cell tumors and could therefore contribute to the occurrence of NHL. We performed a nested case-control study including 155 incident NHL cases and matched noncancer controls. Pre-NHL serum was tested for KSHV DNA and antibodies. Serum KSHV DNA was more common in cases than controls (14% versus 6%, P = 0.03), but after adjustment, the difference was not significant. Epstein-Barr virus serum DNA was similarly unassociated with NHL as were KSHV antibodies. KSHV is not a primary cause of NHL in HIV-infected men who have sex with men.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21116187      PMCID: PMC3073851          DOI: 10.1097/QAI.0b013e3181ff976b

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  23 in total

1.  The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).

Authors:  P S Moore
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

2.  Identifying human herpesvirus 8 infection: performance characteristics of serologic assays.

Authors:  E A Engels; D Whitby; P B Goebel; A Stossel; D Waters; A Pintus; L Contu; R J Biggar; J J Goedert
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-01       Impact factor: 3.731

3.  No increased human herpesvirus 8 seroprevalence in patients with HIV-associated non-Hodgkin's lymphoma.

Authors:  L Gérard; F Agbalika; J Sheldon; A Maillard; T F Schulz; E Oksenhendler
Journal:  J Acquir Immune Defic Syndr       Date:  2001-02-01       Impact factor: 3.731

4.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2000-11-15       Impact factor: 13.506

5.  High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

Authors:  Eric Oksenhendler; Emmanuelle Boulanger; Lionel Galicier; Ming-Qing Du; Nicolas Dupin; Tim C Diss; Rifat Hamoudi; Marie-Thérèse Daniel; Félix Agbalika; Chris Boshoff; Jean-Pierre Clauvel; Peter G Isaacson; Véronique Meignin
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

6.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

7.  Cancer risk among participants in the women's interagency HIV study.

Authors:  Nancy A Hessol; Eric C Seaberg; Susan Preston-Martin; L Stewart Massad; Henry S Sacks; Sylvia Silver; Sandra Melnick; Ovadia Abulafia; Alexandra M Levine
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-01       Impact factor: 3.731

8.  The Multicenter AIDS Cohort Study: retention after 9 1/2 years.

Authors:  J Dudley; S Jin; D Hoover; S Metz; R Thackeray; J Chmiel
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

9.  Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma.

Authors:  E A Engels; P S Rosenberg; M Frisch; J J Goedert
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

10.  Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1997
View more
  1 in total

1.  Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.

Authors:  Gordana Halec; Tim Waterboer; Nicole Brenner; Julia Butt; W David Hardy; Gypsyamber DʼSouza; Steven Wolinsky; Bernard J Macatangay; Michael Pawlita; Roger Detels; Otoniel Martínez-Maza; Shehnaz K Hussain
Journal:  J Acquir Immune Defic Syndr       Date:  2019-03-01       Impact factor: 3.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.